These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 19035101)

  • 1. [Research of high frequency induced thermotherapy efficiency for treatment of hepatocellular carcinoma].
    Lu LG; Hu BS; Li Y; Luo PF; Chen XM
    Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(23):1618-20. PubMed ID: 19035101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of combined percutaneous radio-frequency ablation and percutaneous ethanol injection after transcatheter arterial chemoembolization for hepatocellular carcinoma].
    Zhang FJ; Wu PH; Zhao M; Gu YK; Zhang L; Tan ZB
    Zhonghua Zhong Liu Za Zhi; 2005 Apr; 27(4):248-50. PubMed ID: 15949431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparision of different interventional therapies for primary liver cancer].
    Liu YM; Qin H; Wang CB; Fang XH; Ma QY
    Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):232-5. PubMed ID: 17649645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Transcatheter hepatic arterial chemoembolization on recurrent hepatocellular carcinoma after resection].
    Ge NL; Ren ZG; Ye SL; Lin ZY; Xia JL; Gan YH; Li LX; Shen YF; Tang ZY
    Zhonghua Zhong Liu Za Zhi; 2005 Jun; 27(6):380-2. PubMed ID: 16117905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Percutaneous radiofrequency ablation combined with transcatheter arterial chemoembolization and percutaneous ethanol injection for recurrent small hepatocellular carcinoma].
    Xu ZM; Wang JH; Zhen ZJ; Chen HW; Cui WZ
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Nov; 26(11):1626-8. PubMed ID: 17121718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival rates according to the Cancer of the Liver Italian Program scores of 345 hepatocellular carcinoma patients after multimodality treatments during a 10-year period in a retrospective study.
    Yamagiwa K; Shiraki K; Yamakado K; Mizuno S; Hori T; Yagi S; Hamada T; Iida T; Nakamura I; Fujii K; Usui M; Isaji S; Ito K; Tagawa S; Takeda K; Yokoi H; Noguchi T
    J Gastroenterol Hepatol; 2008 Mar; 23(3):482-90. PubMed ID: 18086115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bridging locoregional therapy for hepatocellular carcinoma prior to liver transplantation.
    Heckman JT; Devera MB; Marsh JW; Fontes P; Amesur NB; Holloway SE; Nalesnik M; Geller DA; Steel JL; Gamblin TC
    Ann Surg Oncol; 2008 Nov; 15(11):3169-77. PubMed ID: 18696158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparable survival in patients with unresectable hepatocellular carcinoma treated by radiofrequency ablation or transarterial chemoembolization.
    Chok KS; Ng KK; Poon RT; Lam CM; Yuen J; Tso WK; Fan ST
    Arch Surg; 2006 Dec; 141(12):1231-6. PubMed ID: 17178966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic effect of transcatheter arterial chemoembolization and percutaneous injection of acetic acids on primary liver cancer.
    Chen HB; Huang Y; Dai DL; Zhang X; Huang ZW; Zhang QK; Wang HH; Zhang JS; Pan G
    Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):55-7. PubMed ID: 14969838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical application of a combination therapy of lentinan, multi-electrode RFA and TACE in HCC.
    Yang P; Liang M; Zhang Y; Shen B
    Adv Ther; 2008 Aug; 25(8):787-94. PubMed ID: 18670743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of mesohepatectomy with or without transcatheter arterial chemoembolization for large centrally located hepatocellular carcinoma.
    Chen XP; Hu DY; Zhang ZW; Zhang BX; Chen YF; Zhang WG; Qiu FZ
    Dig Surg; 2007; 24(3):208-13. PubMed ID: 17522469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive factors for distant recurrence of HCV-related hepatocellular carcinoma after radiofrequency ablation combined with chemoembolization.
    Fuke H; Sugimoto K; Shiraki K; Tanaka J; Beppu T; Yoneda K; Yamamoto N; Ito K; Takaki H; Nakatsuka A; Yamakado K; Takeda K; Takei Y
    Aliment Pharmacol Ther; 2008 Jun; 27(12):1253-60. PubMed ID: 18221404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of combinated transcatheter hepatic artery chemoembolization and factors affecting the prognosis in patients with primary hepatic carcinoma].
    Li CX; Zhang Y; Gao L
    Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):942-5. PubMed ID: 17533749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients with advanced primary hepatocellular carcinoma treated by melatonin and transcatheter arterial chemoembolization: a prospective study.
    Yan JJ; Shen F; Wang K; Wu MC
    Hepatobiliary Pancreat Dis Int; 2002 May; 1(2):183-6. PubMed ID: 14607735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival benefit of transcatheter arterial chemoembolization in patients with hepatocellular carcinoma larger than 10 cm in diameter.
    Huang YH; Wu JC; Chen SC; Chen CH; Chiang JH; Huo TI; Lee PC; Chang FY; Lee SD
    Aliment Pharmacol Ther; 2006 Jan; 23(1):129-35. PubMed ID: 16393290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Necrosis and apoptosis in hepatocellular carcinoma following low-dose versus high-dose preoperative chemoembolization.
    Lu W; Li YH; He XF; Zhao JB; Chen Y; Mei QL
    Cardiovasc Intervent Radiol; 2008; 31(6):1133-40. PubMed ID: 18584240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Transarterial oily chemoembolization combined with interstitial laser thermotherapy for treatment of hepatocellular carcinoma].
    Zhou ZJ; Xu RD; Li WK; Zhuang WX; Lu LG; Shao PJ; Chen XM; Luo PF
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Dec; 27(12):1866-8. PubMed ID: 18159005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicentre randomised phase III trial comparing Tamoxifen alone or with Transarterial Lipiodol Chemoembolisation for unresectable hepatocellular carcinoma in cirrhotic patients (Fédération Francophone de Cancérologie Digestive 9402).
    Doffoël M; Bonnetain F; Bouché O; Vetter D; Abergel A; Fratté S; Grangé JD; Stremsdoerfer N; Blanchi A; Bronowicki JP; Caroli-Bosc FX; Causse X; Masskouri F; Rougier P; Bedenne L;
    Eur J Cancer; 2008 Mar; 44(4):528-38. PubMed ID: 18242076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Median survival time of patients after transcatheter chemo-embolization for hepatocellular carcinoma.
    Haider Z; ul Haq T; Munir K; Usman MU; Azeemuddin M
    J Coll Physicians Surg Pak; 2006 Apr; 16(4):265-9. PubMed ID: 16624189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapeutic effect and prognosis of interferon therapy after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma associated with hepatitis B virus].
    Gao J; Li XS; Shen W; Wu XC; Feng XX; Ren H
    Zhonghua Gan Zang Bing Za Zhi; 2004 Aug; 12(8):460-2. PubMed ID: 15329203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.